MuhnOKuroweckiDPatlasMNAlabousiA. Biparametric prostate MRI: a practical approach to implementation and comparative analysis. Can Assoc Radiol J. Published online May 26, 2025. doi:10.1177/08465371251342706
2.
HuhJParkK. A cost-benefit comparison of biparametric magnetic resonance imaging versus conventional prostate cancer screening. J Urol Oncol. 2023;21(2):121-127.
3.
AbramsonMDeMasiMZhuD, et al. Biparametric versus multiparametric MRI for the detection of clinically significant prostate cancer in a diverse, multiethnic population. Abdom Radiol (NY). 2024;49(7):2491-2498.
4.
TwiltJJSahaABosmaJS, et al. Evaluating biparametric versus multiparametric magnetic resonance imaging for diagnosing clinically significant prostate cancer: an international, paired, noninferiority, confirmatory observer study. Eur Urol. 2025;87(2):240-250. doi:10.1016/j.eururo.2024.09.035
5.
CaglicISushentsevNSyerTLeeKLBarrettT. Biparametric MRI in prostate cancer during active surveillance: is it safe?Eur Radiol. 2024;34(10):6217-6226.
6.
BourneRPanagiotakiE. Limitations and prospects for diffusion-weighted MRI of the prostate. Diagnostics (Basel). 2016;6(2):21. doi:10.3390/diagnostics6020021
